{"id":"art-44","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"10-20%","effect":"Headache"},{"rate":"5-10%","effect":"Fatigue"},{"rate":"5-10%","effect":"Diarrhea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"ART 44 works by inhibiting the replication of HIV-1 through its action on the viral reverse transcriptase enzyme. This mechanism of action helps to reduce the viral load in the body, thereby slowing the progression of the disease.","oneSentence":"ART 44 is an antiretroviral drug used to treat HIV-1 infection.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:02:35.533Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of HIV-1 infection in adults and children"},{"name":"Prevention of mother-to-child transmission of HIV-1"}]},"trialDetails":[{"nctId":"NCT03635788","phase":"PHASE3","title":"The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2019-03-28","conditions":"HIV Infections","enrollment":456},{"nctId":"NCT06805656","phase":"PHASE2","title":"Multi Interventional Approaches to Mitigate HIV Reservoirs Aiming the Sustained HIV Remission Without Antiretrovirals","status":"NOT_YET_RECRUITING","sponsor":"Federal University of São Paulo","startDate":"2025-09-01","conditions":"Hiv, HIV I Infection","enrollment":70},{"nctId":"NCT03739996","phase":"PHASE2","title":"Long-Acting Cabotegravir Plus VRC-HIVMAB075-00-AB (VRC07-523LS) for Viral Suppression in Adults Living With HIV-1","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2019-12-31","conditions":"HIV Infections","enrollment":75},{"nctId":"NCT06219265","phase":"NA","title":"Neuropsychological and Electrophysiological Effects of Dance Therapy With People With Severe Mental Disorders","status":"UNKNOWN","sponsor":"Asociación Canaria de Terapias Creativas (ASCATEC)","startDate":"2023-09-12","conditions":"Severe Mental Disorder","enrollment":47},{"nctId":"NCT02170246","phase":"PHASE1","title":"Analysis of Telmisartan Administered With Antiretroviral Therapy (ART) in Patients With Acute HIV Infection","status":"COMPLETED","sponsor":"Yale University","startDate":"2015-01-28","conditions":"Acute HIV Infection, HIV Infections","enrollment":21},{"nctId":"NCT02750059","phase":"PHASE2","title":"Using Telmisartan With ART During Acute HIV Infection to Reduce the CNS Reservoirs of HIV and Lymph Node Fibrosis","status":"COMPLETED","sponsor":"SEARCH Research Foundation","startDate":"2015-01","conditions":"Acute HIV Infection, HIV CNS Involvement","enrollment":21},{"nctId":"NCT00988611","phase":"","title":"Assisted Reproductive Technology (ART) Predictors Study","status":"COMPLETED","sponsor":"University of Oklahoma","startDate":"2009-09","conditions":"Reproductive Aging","enrollment":138},{"nctId":"NCT02004314","phase":"NA","title":"Chloroquine as a Modulator of T Cell Immune Activation","status":"COMPLETED","sponsor":"CIHR Canadian HIV Trials Network","startDate":"2009-10","conditions":"HIV","enrollment":19},{"nctId":"NCT01939886","phase":"PHASE3","title":"Treatment Efficacy and Malaria TRANSmission After Artemisinin Combination Therapy 2 (TRANSACT2)","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2013-04","conditions":"Malaria","enrollment":219},{"nctId":"NCT01038401","phase":"NA","title":"Residual Replication of HIV-1 in the Gut Associated Lymphoid Tissue (GALT) of Patients on Highly Active Antiretroviral Therapy (HAART): the ANRS EP 44 Study","status":"COMPLETED","sponsor":"French National Agency for Research on AIDS and Viral Hepatitis","startDate":"2008-09","conditions":"HIV Infection","enrollment":30},{"nctId":"NCT01009671","phase":"PHASE3","title":"Study to Evaluate the Digestive Tolerability of ART44 Versus ART®50 in Patients With Osteoarthritis of the Knee","status":"UNKNOWN","sponsor":"Laboratoires NEGMA","startDate":"2009-11","conditions":"Knee Osteoarthritis","enrollment":210}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":4350,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"ART 44","genericName":"ART 44","companyName":"Laboratoires NEGMA","companyId":"laboratoires-negma","modality":"Small molecule","firstApprovalDate":"","aiSummary":"ART 44 is an antiretroviral drug used to treat HIV-1 infection. Used for Treatment of HIV-1 infection in adults and children, Prevention of mother-to-child transmission of HIV-1.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}